SLC33A1 and progeroid syndrome: The results presented in this study indicate that ATase inhibition not only prevents the progression of the progeria-like phenotype of AT-1 sTg mice, but also rescues ongoing disease manifestations of the animals, thus suggesting that inhibition of the ATases and recovery of proteostasis within the ER might have translational potential for diseases characterized by defective ER proteostasis.